Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Itraconazole and Ketoconazole: Oral Itraconazole 200mg od.
Topical Ketoconazole 2% bd.
Control Intervention1: Terbinafine and Ketoconazole: Oral Terbinafine 250mg od.
Topical Ketoconazo
Sponsors
meenakshi medical college hospital and research institute
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patient with diagnosis of tinea corporis and tinea cruris confirmed by KOH microscopy. 2)Patients for whom documented consent has been obtained regarding their voluntary participation in this clinical study. 3)Patients aged 18 years or older at the time that they provide consent. 4)Patient agrees not to take other treatments than those provided in the study.
Exclusion criteria
Exclusion criteria: 1)Patient below 18 years of age. 2)Pregnant and lactating mothers. 3)Patient who are immunocompromised due to disease or drugs. 4)Patient with pre existing renal,hepatic diseases and cardiac failure. 5)Patient with history of hypersensitivity to itraconazole, terbinafine and ketoconazole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients overall satisfaction from the condition Timepoint: baseline and at 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactKumaravel S
Meenakshi Medical College
Outcome results
None listed